Filed: 11/14/2023ACC: 0001999371-23-000200
📋 What this filing means
AFFINITY ASSET ADVISORS, LLC filed this quarterly 13F‑HR report disclosing 74 equity positions with a total reported market value of $355.50M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
74
Positions
$355.50M
Total AUM (reported)
47.31M
Total Shares
Allocation by class
COM$217.73M61.2%
SPONSORED ADS$45.21M12.7%
COM NEW$18.60M5.2%
SHS$17.42M4.9%
NOTE 2.500% 3/1$16.41M4.6%
COMMON STOCK$14.35M4.0%
SPONSORED ADR$8.41M2.4%
Portfolio Concentration
Top 3$72.48M20.4%
4–10$104.78M29.5%
11–25$102.54M28.8%
Rest$75.70M21.3%
Top 3 weight
20.4%
Top 10 weight
49.9%
Voting Authority Distribution
Total shares with voting rights: 47.31M
Sole
Full voting authority
47.31M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole74
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings74
Rows:
TEVA PHARMACEUTICAL INDS LTD
SOLEShares3.10M
TypeSH
Market value$31.62M
8.89%
Sole
3.10M
Shared
0.00
None
0.00
APOGEE THERAPEUTICS INC
SOLEShares1.05M
TypeSH
Market value$22.26M
6.26%
Sole
1.05M
Shared
0.00
None
0.00
ESTABLISHMENT LABS HLDGS INC
SOLEShares379.11K
TypeSH
Market value$18.60M
5.23%
Sole
379.11K
Shared
0.00
None
0.00
CYMABAY THERAPEUTICS INC
SOLEShares1.13M
TypeSH
Market value$16.84M
4.74%
Sole
1.13M
Shared
0.00
None
0.00
IMMUNOVANT INC
SOLEShares428.10K
TypeSH
Market value$16.43M
4.62%
Sole
428.10K
Shared
0.00
None
0.00
BRIDGEBIO PHARMA INC
SOLEShares17M
TypePRN
Market value$16.41M
4.62%
Sole
17M
Shared
0.00
None
0.00
CEREVEL THERAPEUTICS HLDNG I
SOLEShares685.06K
TypeSH
Market value$14.95M
4.21%
Sole
685.06K
Shared
0.00
None
0.00
ARCELLX INC
SOLEShares400K
TypeSH
Market value$14.35M
4.04%
Sole
400K
Shared
0.00
None
0.00
CRINETICS PHARMACEUTICALS IN
SOLEShares450K
TypeSH
Market value$13.38M
3.76%
Sole
450K
Shared
0.00
None
0.00
MADRIGAL PHARMACEUTICALS INC
SOLEShares85K
TypeSH
Market value$12.41M
3.49%
Sole
85K
Shared
0.00
None
0.00
XENON PHARMACEUTICALS INC
SOLEShares300.44K
TypeSH
Market value$10.26M
2.89%
Sole
300.44K
Shared
0.00
None
0.00
ALKERMES PLC
SOLEShares300K
TypeSH
Market value$8.40M
2.36%
Sole
300K
Shared
0.00
None
0.00
KURA ONCOLOGY INC
SOLEShares856.53K
TypeSH
Market value$7.81M
2.20%
Sole
856.53K
Shared
0.00
None
0.00
ASTRIA THERAPEUTICS INC
SOLEShares1M
TypeSH
Market value$7.46M
2.10%
Sole
1M
Shared
0.00
None
0.00
MORPHIC HLDG INC
SOLEShares320K
TypeSH
Market value$7.33M
2.06%
Sole
320K
Shared
0.00
None
0.00
VIKING THERAPEUTICS INC
SOLEShares632.60K
TypeSH
Market value$7.00M
1.97%
Sole
632.60K
Shared
0.00
None
0.00
ARK ETF TR
SOLEShares250K
TypeSH
Market value$6.96M
1.96%
Sole
250K
Shared
0.00
None
0.00
CYTOKINETICS INC
SOLEShares230.37K
TypeSH
Market value$6.79M
1.91%
Sole
230.37K
Shared
0.00
None
0.00
KRYSTAL BIOTECH INC
SOLEShares57.50K
TypeSH
Market value$6.67M
1.88%
Sole
57.50K
Shared
0.00
None
0.00
CENTESSA PHARMACEUTICALS PLC
SOLEShares1.02M
TypeSH
Market value$6.59M
1.85%
Sole
1.02M
Shared
0.00
None
0.00
APELLIS PHARMACEUTICALS INC
SOLEShares170K
TypeSH
Market value$6.47M
1.82%
Sole
170K
Shared
0.00
None
0.00
VERONA PHARMA PLC
SOLEShares368.33K
TypeSH
Market value$6.00M
1.69%
Sole
368.33K
Shared
0.00
None
0.00
INOZYME PHARMA INC
SOLEShares1.38M
TypeSH
Market value$5.80M
1.63%
Sole
1.38M
Shared
0.00
None
0.00
AUTOLUS THERAPEUTICS PLC
SOLEShares1.99M
TypeSH
Market value$4.64M
1.31%
Sole
1.99M
Shared
0.00
None
0.00
SAVARA INC
SOLEShares1.15M
TypeSH
Market value$4.35M
1.22%
Sole
1.15M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
TEVA PHARMACEUTICAL INDS LTDSOLE | SPONSORED ADS | 3.10M | SH | $31.62M 8.89% | 3.10M | 0.00 | 0.00 |
APOGEE THERAPEUTICS INCSOLE | COM | 1.05M | SH | $22.26M 6.26% | 1.05M | 0.00 | 0.00 |
ESTABLISHMENT LABS HLDGS INCSOLE | COM | 379.11K | SH | $18.60M 5.23% | 379.11K | 0.00 | 0.00 |
CYMABAY THERAPEUTICS INCSOLE | COM | 1.13M | SH | $16.84M 4.74% | 1.13M | 0.00 | 0.00 |
IMMUNOVANT INCSOLE | COM | 428.10K | SH | $16.43M 4.62% | 428.10K | 0.00 | 0.00 |
BRIDGEBIO PHARMA INCSOLE | NOTE 2.500% 3/1 | 17M | PRN | $16.41M 4.62% | 17M | 0.00 | 0.00 |
CEREVEL THERAPEUTICS HLDNG ISOLE | COM | 685.06K | SH | $14.95M 4.21% | 685.06K | 0.00 | 0.00 |
ARCELLX INCSOLE | COMMON STOCK | 400K | SH | $14.35M 4.04% | 400K | 0.00 | 0.00 |
CRINETICS PHARMACEUTICALS INSOLE | COM | 450K | SH | $13.38M 3.76% | 450K | 0.00 | 0.00 |
MADRIGAL PHARMACEUTICALS INCSOLE | COM | 85K | SH | $12.41M 3.49% | 85K | 0.00 | 0.00 |
XENON PHARMACEUTICALS INCSOLE | COM | 300.44K | SH | $10.26M 2.89% | 300.44K | 0.00 | 0.00 |
ALKERMES PLCSOLE | SHS | 300K | SH | $8.40M 2.36% | 300K | 0.00 | 0.00 |
KURA ONCOLOGY INCSOLE | COM | 856.53K | SH | $7.81M 2.20% | 856.53K | 0.00 | 0.00 |
ASTRIA THERAPEUTICS INCSOLE | COM | 1M | SH | $7.46M 2.10% | 1M | 0.00 | 0.00 |
MORPHIC HLDG INCSOLE | COM | 320K | SH | $7.33M 2.06% | 320K | 0.00 | 0.00 |
VIKING THERAPEUTICS INCSOLE | COM | 632.60K | SH | $7.00M 1.97% | 632.60K | 0.00 | 0.00 |
ARK ETF TRSOLE | GENOMIC REV ETF | 250K | SH | $6.96M 1.96% | 250K | 0.00 | 0.00 |
CYTOKINETICS INCSOLE | COM NEW | 230.37K | SH | $6.79M 1.91% | 230.37K | 0.00 | 0.00 |
KRYSTAL BIOTECH INCSOLE | COM | 57.50K | SH | $6.67M 1.88% | 57.50K | 0.00 | 0.00 |
CENTESSA PHARMACEUTICALS PLCSOLE | SPONSORED ADS | 1.02M | SH | $6.59M 1.85% | 1.02M | 0.00 | 0.00 |
APELLIS PHARMACEUTICALS INCSOLE | COM | 170K | SH | $6.47M 1.82% | 170K | 0.00 | 0.00 |
VERONA PHARMA PLCSOLE | SPONSORED ADS | 368.33K | SH | $6.00M 1.69% | 368.33K | 0.00 | 0.00 |
INOZYME PHARMA INCSOLE | COM | 1.38M | SH | $5.80M 1.63% | 1.38M | 0.00 | 0.00 |
AUTOLUS THERAPEUTICS PLCSOLE | SPON ADS | 1.99M | SH | $4.64M 1.31% | 1.99M | 0.00 | 0.00 |
SAVARA INCSOLE | COM | 1.15M | SH | $4.35M 1.22% | 1.15M | 0.00 | 0.00 |
Page 1 of 3